Search
LeMaitre Vascular Inc
LMATAdd to Watchlist
93.950USD
+1.740+1.89%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
2.15BMarket Cap
34.16P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of LeMaitre Vascular Inc is 7.78, ranking 118 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 108.00, with a high of 120.00 and a low of 90.00.
Analyst Rating
Based on
9
analysts
Buy
Current Rating
118.750
Target Price
+26.40%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
94
Total
3
Median
7
Average
Company name
Ratings
Analysts
LeMaitre Vascular Inc
LMAT
9
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Veeva Systems Inc
VEEV
30
Thermo Fisher Scientific Inc
TMO
30
1
2
3
...
19
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is LeMaitre Vascular Inc's expected revenue for the next quarter?
LeMaitre Vascular Inc's expected revenue is 71.47M.
What is LeMaitre Vascular Inc's price target?
Analysts forecast that LeMaitre Vascular Inc's price target is USD 108.00, with the highest forecast at USD 120.00 and the lowest forecast at USD 90.00.
How have LeMaitre Vascular IncLMAT's recent earnings per share performed?
The market expectation was USD 0.69, while LeMaitre Vascular IncLMAT's earnings per share (EPS) for the previous quarter was USD 2.55. EPS for the next quarter is expected at USD 0.81.
What is the analyst rating for LeMaitre Vascular Inc?
Based on the ratings of LeMaitre Vascular Inc's stock from 9 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
